Australia's most trusted
source of pharma news
Posted 16 June 2026 PM
AstraZeneca is in trouble with the UK industry watchdog again after 18 of its employees - including four senior managers - interacted with a LinkedIn post.
A medical professional complained to the Prescription Medicines Code of Practice Authority (PMCPA) in September last year, three months after AZ employees had reacted to a post, published by an independent organisation, announcing that AZ's cancer drug Lynparza had been the joint winner of an award in the "Best Pharmaceutical Product" category.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.